Results 1 to 10 of about 45 (45)
Pharmacogenetic Aspects of Type 2 Diabetes Treatment
In this article, we analyze the role of different variants of the KCNJ11, TCF7L2, SLC22A1, SLC22A3, CYP2C9, CYP2C8, PPARγ genes polymorphisms in efficacy of diabetes mellitus pharmacotherapy.
N. O. Pozdnyakov +9 more
doaj +1 more source
Polymorphic variants of the multidrug resistance gene (ABCB1 or MDR1) are associated with changes in the absorption and transport of drugs in the body.
A. Yu. Sambyalova +10 more
doaj +1 more source
В работе в формате вопрос-ответ рассмотрен новый взгляд на проблему подбора антикоагулятной терапии. Дано представление о фармакогенетике варфарина и особенносях генетического подхода к подбору терапии.
Е. С. Кропачева
doaj +1 more source
Тардивная дискинезия:успехи современной фармакогенетики
Тардивная дискинезия (ТД) является серьезным побочным эффектом долгосрочного воздействия антипсихотических препаратов. Она харак теризуется непроизвольными движениями туловища, конечностей и орофациальных мышц.
Федоренко, О.Ю. +3 more
doaj +1 more source
Цель: Изучение роли носительства полиморфного варианта гена LEP (rs3828942) в развитии антипсихотикиндуцированных нарушении углеводного обмена у пациентов с шизофрениеи, постоянно проживающих в европеискои части Россиискои Федерации. Материалы и методы:
Добродеева, В.С. +4 more
doaj +1 more source
The clinical significance of the patient genetic characteristics in the individual pharmacological response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral anticoagulants choice on the basis of pharmacogenetic ...
D. A. Sychev +3 more
doaj +1 more source
Introduction. Antipsychotics are the main drugs for treatment of schizophrenia spectrum disorders. Pharmacodynamic genetic factors are being actively studied to improve the accuracy of antipsychotic selection based on pharmacogenetic testing.
D. V. Ivaschenko +11 more
doaj +1 more source
PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
Aim. To study what cardiac drugs currently have any comments on biomarkers and what information can be obtained by pharmacogenetic testing using data exome sequencing in patients with cardiac diseases.Material and methods.
N. V. Shcherbakova +5 more
doaj +1 more source
Clinical Pharmacology in Health Care, Teaching and Research
Published jointly by CIOMS, IUPHAR and WHO in 2012 under the title "Clinical Pharmacology in Health Care, Teaching and Research".Russian Association of Clinical Pharmacologists is gratefully acknowledged for its generous support to make this publication ...
Article Editorial
doaj +1 more source
Introduction. Pharmacokinetic genetic factors are prognostically relevant when prescribing antipsychotics to adult patients. Currently, there is a dearth of research on adolescents with an acute psychotic episode. Aim.
D. V. Ivaschenko +10 more
doaj +1 more source

